Drugs / VCH-759
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00389298 | Oct 2006 → Jun 2007 | chronic hepatitis C virus infection | Vertex Pharmaceuticals Incorporated | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VCH-759 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00389298 ↗ |
| Known as | BCH-27759 | “VCH-759 (BCH-27759)” NCT00389298 ↗ |
| Modality | Small molecule | — CHEMBL1741078 ↗ |
| Route | Oral | “orally administered VCH-759” NCT00389298 ↗ |